India Medical Tourism Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

Market Trends and Insights

Cost Advantage of Complex Surgeries Vs OECD Nations

Hospital savings can leave room to finance an overseas treatment journey when the offer fits the patient's clinical needs. In May 2026, India’s government said high-quality treatment was often substantially less costly than in many developed countries. A British patient underwent bilateral knee replacement at Max Smart Super Speciality Hospital in Saket after his UK National Health Service (NHS) pathway could not offer simultaneous surgery. In an August 2026 report, The Medical Travel Company said the India package reportedly cost about GBP 14,000 (USD 18,960), compared with a UK procedure estimate of around GBP 40,000 (USD 54,180). The India package reportedly included flights, accommodation, meals, insurance, and clinical care. That breadth makes the package's coverage central to affordability, alongside the treatment price, for patients comparing the cost of traveling with their domestic option.

Expanding Network Of JCI/NABH-Accredited Hospitals

An overseas patient needs a credible basis for assessing a hospital before entering an unfamiliar healthcare system. In May 2026, the government reported that the National Accreditation Board for Hospitals and Healthcare Providers (NABH) had accredited over 1,299 Indian hospitals using more than 600 safety parameters. Separately, Kauvery Hospital Vadapalani received Joint Commission International (JCI) accreditation in Chennai on January 31, 2025.^[1] A national accreditation base of that size and individual JCI awards give an overseas patient a verifiable quality check before choosing between hospitals, especially when facilities cannot be inspected before travel. Hospitals without either accreditation face a harder task substantiating their safety proposition to those overseas patients.

‘Heal In India’ Campaign & Streamlined E-Medical Visa

International treatment requires a workable journey for both the patient and any accompanying caregiver. In May 2026, the government described Heal in India as an initiative positioning India for integrated and holistic healthcare. It also reported extending e-Medical Visa and e-Medical Attendant Visa facilities to nationals of 172 countries.^[2] Covering both travelers can reduce the administrative mismatch between arranging treatment and arranging essential personal support. Destination promotion and visa access therefore address different obstacles, with the former attracting consideration and the latter enabling eligible families to organize travel. The practical gain is a wider eligible referral pool for hospitals serving patients who need someone to accompany them.

Advanced Robotics & Transplant Technology Adoption

Robotic adoption can broaden the procedures an Indian hospital is equipped to coordinate, including treatment involving a donor and recipient. Apollo Hospitals reported completing more than 8,000 robotic-assisted surgeries across multiple specialties in Chennai by February 12, 2026.^[3] A July 2025 report described simultaneous kidney transplant operations using separate robotic systems at Fortis Hospital Bannerghatta Road, Bengaluru, involving a 35-year-old woman from Bijapur, Karnataka, and her brother, both recovering well within a week. The paired procedure illustrates how adoption can change the organization of a transplant episode beyond adding another surgical device. For an overseas family considering a similar procedure, the capability could support treatment of both an eligible donor and recipient at one hospital. Offering simultaneous robotic operations requires access to separate systems, giving equipped transplant centers a more specialized proposition than robotic surgery alone.

Hygiene & Safety Perception Issues Post-COVID-19

Safety concerns can undermine a treatment proposition even when the concern arises outside the hospital. After a June 2026 fire at a Delhi budget hotel frequented by foreign nationals seeking medical treatment, stakeholders reported patient questions about accommodation safety. They also anticipated closer scrutiny of safety certificates and emergency exits before families made bookings. This creates an additional decision hurdle for a patient comparing a treatment offer with the practical conditions of recovery nearby. PSRI Hospital said in June 2026 that it was sharing details of lodging facilities with valid safety certifications. Such information can help families assess options, but accommodation verification adds work to arranging an affordable treatment journey.

Airport & Surface-Transport Bottlenecks

West Asia air-travel disruption amid the US-Israel-Iran conflict began in February 2026, affecting routes used for treatment journeys to India. Ruby Hall Clinic in Pune reported a 20% to 30% drop in international patient inflow over the 2 weeks before March 19, 2026. The hospital reported more elective-procedure cancellations, while emergency and critical-care cases continued with minimal disruption amid airspace closures, flight suspensions, and rising fares. Elective treatment is especially exposed when a patient can postpone travel rather than accept a less predictable journey. For hospitals serving that demand, a competitive treatment offer cannot by itself resolve disrupted access to the destination. Transport uncertainty can therefore leave elective capacity harder to fill and patients facing rescheduling or higher travel costs.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

India Medical Tourism Market Segment Analysis

Cardiovascular surgery accounted for a 22.22% share of the India medical tourism market size in 2026, making it the largest segment. Apollo Heart Institute reports more than 250,000 cardiac surgeries across its network in India. That cumulative scale gives an overseas patient comparing cardiac programs a measurable indicator of surgical experience. For a newer unit competing for the same complex cases, building a comparable record requires treating patients over time. Established cardiac networks can therefore compete on demonstrated surgical experience as well as the proposed intervention.

Oncology treatment is forecast to be the fastest-growing segment, at a CAGR of 15.8% over 2027-2032. HealthCare Global Enterprises Limited announced the launch of its North Bengaluru cancer hospital on May 19, 2026, with up to 132 beds. The facility introduced Karnataka's first Elekta Unity MR-Linac, a precision radiation therapy platform. Specialized capacity becomes a stronger international proposition when a referring clinician can identify a case that calls for the facility’s precision-radiation capability. The launch gave HCG an early position in Karnataka for referrals requiring MR-guided radiation, making technology-specific case selection more valuable than undifferentiated promotion.

Private multispecialty corporate hospitals represented a 66.11% India medical tourism market share in 2026, making them the largest segment. At June 30, 2026, Apollo Hospitals had 8,352 operating beds, excluding Apollo Health and Lifestyle and managed beds. Its overall occupancy was 70%, compared with 65% a year earlier. A broad bed base can support several treatment teams within one institutional relationship. With a larger proportion of beds occupied, additional overseas admissions must compete for the capacity left after existing patient demand.

Medical tourism facilitators are forecast to be the fastest-growing segment, with a CAGR of 14.7% over 2027-2032. In June 2025, Vaidam acquired MediJourney, a digital platform assisting international patients seeking treatment in India. The transaction creates an opportunity to connect the facilitator's service business with an additional digital interface for international patient inquiries. MediJourney retained its brand under Vaidam's ownership. For Vaidam, the acquisition's commercial value depends partly on differentiating the two brands' referral propositions and limiting overlapping patient-acquisition spending.

Patients aged 46 to 65 formed the largest segment, accounting for a 43.22% share of the market in 2026. In September 2025, a 55-year-old Kenyan woman underwent a kidney transplant at the Asian Institute of Nephrology and Urology in Hyderabad. Unable to find suitable treatment in Kenya, she traveled to India with her daughter and sister, and the sister became the living donor after compatibility testing and medical assessments. This episode illustrates an access-led treatment decision in which a feasible specialist intervention supplied the reason for an overseas journey. For cases involving a relative donor, the hospital's commercial relationship extends to both donor assessment and recipient treatment, rather than the recipient's intervention alone.

Patients aged 66 and older are forecast to be the fastest-growing segment, with a CAGR of 12.8% over 2027-2032. In 2025, Fortis Escorts, Okhla, treated a 72-year-old woman from Bangladesh with robot-assisted heart bypass followed by breast cancer surgery in a single session lasting around 11 hours. The patient was discharged in stable condition after 12 days. The case illustrates why an older traveler's treatment proposition can depend on coordinating care for concurrent cardiac and cancer conditions. Hospitals able to coordinate both specialties can therefore compete for the complete cardiac-oncology episode, including the recovery stay after a combined intervention.

Male patients formed the largest segment, accounting for 55.27% of the market in 2026. A March 2025 report described Sakra World Hospital in Bengaluru removing a large meningioma from a 34-year-old international patient from Ghana. The team managed his postoperative anemia without transfusion in accordance with his religious beliefs. The case illustrates how a hospital's ability to accommodate a specific clinical constraint can be central to the treatment proposition for an individual overseas buyer. Blood-conserving surgical expertise can therefore differentiate an individual program for overseas patients with transfusion restrictions.

Female patients are forecast to be the fastest-growing segment, with a CAGR of 13.1% over 2027-2032. A Kenyan woman arrived in Mumbai on July 2, 2025, for breast cancer care at Kokilaben Dhirubhai Ambani Hospital, where she underwent surgery and chemotherapy. She completed radiotherapy that began in January 2026. Her treatment illustrates how a single overseas patient's care can span several stages over months, extending the provider relationship beyond the first intervention. For such episodes, follow-on oncology services can be as commercially important as the initial admission.

Geography Analysis

South India Medical Tourism Market

South India accounted for a 33.18% India medical tourism market share in 2026, making it the largest regional segment. On June 30, 2026, Apollo Hospitals in Chennai marked a cumulative milestone of treating more than 500,000 patients from Bangladesh. Experience with a defined source-country patient population can support a more specific service proposition than a general claim of international reach, especially before a patient travels. For Chennai's established providers, Bangladesh-focused referral development can therefore draw on demonstrated treatment experience rather than destination promotion alone.

East & Northeast India Medical Tourism Market

East & Northeast India is forecast to be the fastest-growing regional segment, with a CAGR of 13.7% over 2027-2032. In September 2026, R N Tagore Narayana Hospitals in Kolkata reported around 250 Bangladeshi patients visiting its outpatient department daily. The hospital also reported that Bangladeshi outpatient footfall had grown by more than 6% over the previous month. Other Kolkata hospitals, including Ruby General Hospital and B P Poddar Hospital, reported declines in Bangladeshi outpatient visits after the August 19, 2026 fire at the Shikha Inn hotel. A B P Poddar Hospital representative cited a lack of affordable accommodation as one reason patients remained reluctant to travel, so lodging availability, and not only the clinical offer, shapes this cross-border flow.

In North India, a February 2026 report described Delhi NCR hospitals receiving international patients for cancer care, transplants, cardiac interventions, and complex orthopedic and neurosurgical procedures. In West India, Apollo Hospitals' Navi Mumbai hospital assists international patients with treatment coordination, medical visas, travel, accommodation, and language interpretation. In Central India, Kokilaben Dhirubhai Ambani Hospital in Indore offers medical-visa invitation letters to eligible patients and one attendant. These examples address different points in a patient's decision, from finding a specialist intervention to obtaining local assistance and entry documentation. Specialty-led referrals favor the Delhi NCR offer, while the Navi Mumbai and Indore services can appeal to eligible patients whose unresolved obstacles concern travel support or documentation.

Regulatory Framework and Outlook

This comparison covers selected jurisdictions from the perspective of a private hospital operator serving international patients. The central Clinical Establishments Act applies where adopted, while Kerala has its own clinical-establishments framework. Separately, an e-Medical Visa application requires a letter on the Indian hospital's letterhead stating the suggested admission or treatment date, connecting travel documentation with the provider's clinical arrangements.

India's rating balances continuing enforcement with the shift toward administrative penalties for specified contraventions, supporting an easing direction after the June 2026 amendments. Kerala's registration and category-based safety duties add operating obligations, while rate displays can help patients compare treatment offers. The Kerala High Court dismissed appeals challenging the Kerala Clinical Establishments Act, 2018 on November 26, 2025, and the State Council later listed a compliance-report notice tied to that judgment. That emphasis on implementing existing duties supports continuity in the commercial requirements facing covered hospitals.

Value Chain Stages

This comparison follows the international patient's journey from clinical assessment through travel coordination to treatment and discharge. Vaidam gathers medical histories and reports, while treating doctors supply the medical opinions and cost estimates used in choosing care. That division places the clinical decision with the provider and makes a clear handoff essential before a facilitator commits the patient to travel arrangements.

Medanta requires international patients to pay a deposit after confirming their appointment, linking financial commitment to an identified place in the care pathway. That commitment makes the accuracy of the clinical and travel handoff commercially important to the provider. Tour2India4Health says its associated hospitals pay it directly for facilitation, so on that stated model its coordination work is a provider-funded route to potential treatment demand. Wider use of that model would connect patient-acquisition spending more closely with hospital-level admission planning.

Key Opportunities for Market Participants

The opportunities compared here concern India's February 1, 2026 proposal to support states in establishing 5 Regional Medical Hubs with private-sector partners. The proposal envisaged complexes combining medical, educational, and research facilities with AYUSH, medical-tourism facilitation, diagnostics, post-care, and rehabilitation. On August 27, 2026, the health ministry reported sharing hub inputs with the Department for Promotion of Industry and Internal Trade. Nodal persons from the Indian Council of Medical Research and the Central Council for Research in Ayurvedic Sciences had also been identified for proposed working groups.

These proposals create a potential entry route for specialized service firms alongside hospital operators. A specialist firm can prepare a defined clinical or coordination service that future participating hospitals could adopt. Major site-specific commitments would depend on announced hub locations and procurement arrangements, making service preparation more feasible than treating the proposal as an available contract.